Wednesday - July 1, 2026
UNC-School of Medicine: Two Popular Diabetes Drugs Outperform Two Others In Head-To-Head Comparison
September 23, 2022
CHAPEL HILL, North Carolina, Sept. 23 (TNSjou) -- The University of North Carolina School of Medicine issued the following news release:

* * *

The national GRADE study, with leadership and participation from UNC School of Medicine's John Buse, MD, PhD, and Sue Kirkman, MD, found that two of four common type 2 diabetes treatments -- glargine and liraglutide -- worked better than the other drugs, sitagliptin and glimepiride, to maintain blood glucose levels.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products